Overexpression of EZH2 protein has been shown in various malignant tumors, including carcinomas of the breast [14], lung [15], stomach [16], colon [17], pancreatobiliary tract [18], liver [19], thyroid gland [20], prostate [21], and bladder [22]. The gene discussed is EZH2; the disease is cancer.